How to Detox From Excess Oestrogen: A Naturopath's Root-Cause Approach
In this article
The symptoms tend to arrive gradually. Periods that were manageable become heavy, clotty, painful. Weight accumulates around the hips and abdomen despite nothing obvious changing in diet or exercise. Mood swings arrive in the week before the period with a regularity that starts to feel like a different person moving in. Sleep deteriorates. Breasts become tender. And somewhere in the mix, a GP runs a blood test, the oestrogen level comes back in the normal reference range, and the conversation stalls.
Here is what that scenario misses: oestrogen dominance is not always about how much oestrogen you have. It is about the ratio between oestrogen and progesterone, the form the oestrogen takes, and critically — how efficiently your body is clearing it. A woman with normal total oestrogen can still be in a state of functional oestrogen dominance if her liver, gut, and methylation pathways are not processing and eliminating it properly.
That is where the root-cause approach starts. Not with the hormone level itself, but with the system responsible for clearing it.
Recognise any of these?
Excess oestrogen or oestrogen dominance commonly presents as:
- Heavy, painful, or clotty periods
- PMS — mood swings, irritability, anxiety or low mood in the luteal phase
- Weight gain around hips, thighs, and abdomen that is resistant to diet changes
- Breast tenderness, fibrocystic breasts, or breast swelling premenstrually
- Fibroids or endometriosis (oestrogen is a primary driver of both)
- Bloating and fluid retention in the second half of the cycle
- Fatigue and brain fog, particularly in the week before the period
- Low libido
- Difficulty losing weight despite caloric restriction
- Irregular cycles or anovulatory cycles
These symptoms share an upstream driver in many women: impaired oestrogen clearance. That is what we investigate.
What oestrogen dominance actually means
Oestrogen dominance describes a state in which oestrogen activity is disproportionately high relative to progesterone. This can happen three ways: oestrogen is genuinely elevated, progesterone is low (which is extremely common in perimenopause and in women with chronic stress), or oestrogen is being metabolised through unfavourable pathways that produce more potent or inflammatory metabolites rather than being safely eliminated.
The third scenario is the one that standard blood testing almost never captures — and it is the one I find most frequently in clinical practice when women come to me with a stack of normal results and a body that clearly is not functioning normally.
It is also worth noting that oestrogen dominance is not exclusively a women's issue. Men carry oestrogen too, and when aromatase activity is high — as it is in obesity, liver dysfunction, and chronic inflammation — men can develop clinically significant oestrogen excess. The mechanisms are the same; the presenting symptoms differ.
The three forms of oestrogen and why they matter clinically
Oestrogen is not a single molecule. The three forms have different biological potencies and clinical significance, and understanding which predominates changes the treatment approach considerably.
Oestradiol (E2) is the most potent form and is the primary oestrogen produced by the ovaries during reproductive years. It drives the menstrual cycle, supports bone density, maintains cardiovascular and cognitive function, and gives skin its elasticity. In excess — or when poorly metabolised — it contributes to heavy bleeding, fibroid growth, endometriosis, and increased breast cancer risk.
Oestrone (E1) is produced primarily by fat cells, the adrenal glands, and the ovaries. It becomes the dominant circulating oestrogen after menopause, when ovarian production of oestradiol drops. Because fat tissue is an oestrogen-producing organ, higher body fat increases oestrone production independent of ovarian function — which is why weight management is a legitimate and clinically significant component of oestrogen balance.
Oestriol (E3) is the weakest of the three and is largely protective. It competes with oestradiol and oestrone for receptor binding without producing the same proliferative effects. Levels rise substantially during pregnancy and drop after. In postmenopausal women, oestriol is used therapeutically in some hormone replacement protocols precisely because of its more favourable receptor profile.
The ratio between these three — particularly the E3/(E1+E2) ratio — is a clinically useful marker. A low oestriol relative to oestradiol and oestrone signals less receptor competition from the protective form and more activity from the proliferative forms.
What drives excess oestrogen
Oestrogen dominance rarely has a single cause. In clinical practice it is almost always multifactorial, with several inputs compounding over time. The most common drivers I see:
Impaired liver detoxification
The liver runs Phase I and Phase II oestrogen metabolism. If either phase is sluggish, oestrogen metabolites accumulate or recirculate instead of being eliminated.
Clinical note: One of the most common and treatable causes — frequently missed because liver enzymes (ALT/AST) appear normal until damage is significant. GGT is a more sensitive early marker.
Dysbiotic gut / beta-glucuronidase activity
Certain gut bacteria produce beta-glucuronidase, which deconjugates oestrogen already processed by the liver for elimination — returning it to active circulation via enterohepatic recirculation.
Clinical note: A disrupted microbiome directly increases circulating oestrogen load. This is why gut health is central to hormone balance and why many hormone protocols only partially work without addressing the gut.
Impaired methylation
The 2-hydroxy oestrogen metabolite requires methylation via the COMT enzyme to be safely eliminated. Poor methylation — common with MTHFR variants or B vitamin deficiency — allows toxic catechol oestrogens to accumulate.
Clinical note: Elevated 4-hydroxy and catechol oestrogen metabolites are associated with DNA damage and increased cancer risk. MTHFR variants affect a significant proportion of the Australian population.
Xenoestrogen exposure
Plastics (BPA, phthalates), pesticides (glyphosate, organochlorines), parabens in personal care products, and synthetic fragrances all bind oestrogen receptors or upregulate aromatase.
Clinical note: Cumulative burden is what matters — no single exposure is usually the problem. The total load across food, water, personal care, and home environment is what the liver has to process daily.
Excess body fat
Adipose tissue converts androgens to oestrogens via the aromatase enzyme. More fat means more aromatase activity and more oestrogen production, independent of ovarian function.
Clinical note: Clinically significant in both women and men. Weight loss directly reduces oestrogen production by reducing the aromatase substrate available.
Chronic stress / cortisol elevation
Cortisol competes with progesterone for shared precursors (pregnenolone). Sustained stress depletes progesterone, shifting the oestrogen:progesterone ratio unfavourably even when oestrogen itself is not elevated.
Clinical note: "Pregnenolone steal" is a real and commonly missed cause of relative oestrogen dominance in high-stress women with otherwise normal oestrogen levels on blood testing.
Low fibre diet
Dietary fibre binds oestrogen metabolites in the gut for elimination. Insufficient fibre allows more enterohepatic recirculation of oestrogen back into circulation.
Clinical note: Australians eat on average 20g of fibre daily — well below the recommended 25-30g. Increasing plant food diversity is one of the most straightforward and evidence-supported dietary changes for oestrogen balance.
Exogenous hormones
The combined oral contraceptive pill, oestrogen-dominant HRT protocols, and some fertility medications add exogenous oestrogen load that the liver must process on top of endogenous production.
Clinical note: Not always avoidable, but worth factoring into the total oestrogen picture — and a strong reason to optimise clearance pathways in women using these medications long-term.
How oestrogen is actually cleared from the body
The liver is the primary site of oestrogen detoxification, and understanding how it works is essential to understanding why "detox" approaches that ignore the liver — or that focus only on diet — frequently underperform.
Oestrogen clearance happens in two hepatic phases, followed by gut elimination. Each step is a potential weak link.
Phase I — Hydroxylation
Cytochrome P450 enzymes (primarily CYP1A1, CYP1B1, and CYP3A4) convert oestradiol and oestrone into hydroxylated metabolites. The pathway taken here determines how safe or dangerous the downstream metabolites are. The 2-hydroxy pathway produces relatively inert metabolites. The 4-hydroxy pathway produces catechol oestrogens that, if not quickly methylated in Phase II, form quinones — molecules that can bind DNA and initiate mutagenic changes. Phase I activity depends on adequate B vitamins, zinc, magnesium, and antioxidants.
Phase II — Conjugation (Methylation, Glucuronidation, Sulfation)
Phase II processes the hydroxylated metabolites for elimination. Methylation via the COMT enzyme neutralises the catechol oestrogens from Phase I — this is where MTHFR gene variants and B12/folate/B6 status become clinically significant. Glucuronidation tags oestrogen metabolites for excretion in bile. Sulfation provides an alternative conjugation route. All three Phase II processes require specific nutrient cofactors, and all three can be impaired by nutrient deficiency, toxic burden, or genetic variation.
Gut Elimination — The Beta-Glucuronidase Problem
Conjugated oestrogen metabolites travel from the liver into the gut via bile for elimination in stool. If gut bacteria produce excessive beta-glucuronidase — an enzyme that cleaves the conjugation tag — oestrogen is deconjugated and reabsorbed into circulation rather than eliminated. This enterohepatic recirculation is one of the most clinically significant and least discussed mechanisms in oestrogen dominance. A dysbiotic gut can substantially increase circulating oestrogen load even when liver detoxification is functioning adequately.
The gut is not just a bystander in oestrogen metabolism. It is an active participant. A disrupted microbiome can recirculate oestrogen that the liver has already processed for elimination — undoing the liver's work entirely.
Struggling with hormonal symptoms that standard testing hasn't explained?
A 20-minute discovery call can clarify whether a functional hormone and gut assessment makes sense for your presentation. No referral required.
Book a free discovery callHow we test for oestrogen dominance
Standard blood testing for oestrogen measures total circulating oestradiol at a single point in the cycle. This tells you the level. It does not tell you the ratio between the three forms, which pathway the oestrogen is being metabolised through, or how efficiently it is being eliminated. For a presentation driven by impaired clearance rather than simply elevated production, a single oestradiol level is a near-useless data point.
The tests I use for a meaningful oestrogen metabolic workup:
Adrenal Cortex Female Hormone Saliva Panel
A four-point salivary collection measuring oestradiol (E2), progesterone, the E2:progesterone ratio, DHEA-S, and diurnal cortisol. Salivary measurement reflects free, bioavailable hormone rather than total bound hormone — which is what matters at the tissue level. This panel gives the oestrogen:progesterone ratio directly, identifies adrenal contributions to the hormonal picture, and maps the cortisol pattern that drives progesterone depletion under chronic stress. It is far more clinically informative than a single serum oestradiol for evaluating oestrogen dominance.
Organic Acids Test (OAT)
The OAT provides indirect but clinically useful information about methylation capacity, B vitamin status, and oxidative stress — all of which directly affect Phase II oestrogen detoxification. Where methylation markers are abnormal, COMT-dependent catechol oestrogen clearance is likely impaired. The OAT also maps gut dysbiosis patterns that correlate with elevated beta-glucuronidase activity.
GI Microbiome Map
For women where gut-driven oestrogen recirculation is suspected — typically those with significant digestive symptoms alongside hormonal symptoms, or those with a history of antibiotic use or highly processed diet — a comprehensive stool analysis is warranted. I look specifically at microbial diversity, the presence of beta-glucuronidase-producing species, and markers of intestinal inflammation. Normalising the microbiome is frequently the missing piece in hormone treatment plans that have achieved partial but not complete results.
Targeted Blood Panel
Beyond the hormone panel itself: liver function (ALT, AST, GGT — GGT being the most sensitive early marker of hepatic stress), SHBG (sex hormone-binding globulin, which affects free oestrogen availability), fasting insulin and HOMA-IR (insulin resistance drives aromatase activity), full thyroid panel, ferritin, and high-sensitivity CRP. These markers contextualise the hormonal picture and identify the metabolic drivers that need addressing alongside direct oestrogen clearance support.
The ROOT Method applied to oestrogen dominance
When a patient presents with the symptom cluster of oestrogen dominance — heavy periods, weight that will not shift, PMS that is derailing her life — the temptation is to reach immediately for DIM or a liver support supplement. Sometimes that helps. More often, it produces a partial response because it addresses one pathway while leaving others untouched.
The ROOT Method: Applied to Oestrogen Dominance
The ROOT Method works through four investigative layers. For oestrogen dominance presentations, each layer has specific clinical content:
- R — Root Cause Identification: Is this excess production (high aromatase, exogenous hormones, excess body fat), impaired clearance (liver Phase I/II dysfunction, gut dysbiosis, impaired methylation), or relative dominance due to low progesterone (stress, anovulation, perimenopause)? The answer changes the entire treatment plan.
- O — Optimise Function: Restoring liver Phase I and Phase II capacity, normalising the gut microbiome to reduce beta-glucuronidase activity, supporting methylation with targeted B vitamin and cofactor therapy, addressing insulin resistance and aromatase drivers, and reducing xenoestrogen burden.
- O — Ongoing Monitoring: Using salivary hormone panels and the OAT to track oestrogen metabolite ratios and methylation capacity over time. Symptom improvement is the outcome we care about — but objective markers tell us whether the underlying mechanisms are actually changing.
- T — Total Health Integration: Diet, gut health, stress physiology, sleep, body composition, and toxic burden all feed into oestrogen metabolism. Treating them as separate problems produces inferior outcomes to treating the whole system.
What actually clears excess oestrogen
I want to be specific here rather than producing a generic supplement list. Every intervention below has a mechanistic rationale and clinical evidence behind it. The right combination for any individual depends on which pathways are impaired — which is what testing determines.
Cruciferous vegetables and DIM / I3C
Cruciferous vegetables — broccoli, cauliflower, Brussels sprouts, kale, cabbage — contain glucosinolates that are converted in the gut to indole-3-carbinol (I3C) and subsequently to diindolylmethane (DIM). These compounds upregulate CYP1A1, shifting Phase I oestrogen metabolism toward the 2-hydroxy pathway (the safer route) and away from the 4-hydroxy pathway. DIM also has direct oestrogenic antagonist activity at some receptor subtypes. The therapeutic dose of supplemental DIM (100-200mg daily) is significantly higher than what diet alone provides, which is why supplementation is often warranted alongside dietary change rather than instead of it.
Liver support — Phase I and Phase II
St Mary's Thistle (silymarin) protects hepatocytes and supports liver regeneration. Globe artichoke and dandelion root stimulate bile production and flow, which is essential for Phase II conjugate elimination. N-acetyl cysteine (NAC) supports glutathione synthesis, which is the primary antioxidant buffer for Phase I oxidative metabolites. B2, B3, and magnesium are essential Phase I cofactors. Glycine and taurine support the glucuronidation and sulfation arms of Phase II. The combination of herbs and targeted nutrients outperforms either alone in clinical practice.
Methylation support
COMT-dependent methylation of catechol oestrogens requires SAMe (S-adenosylmethionine) as the methyl donor, and the methylation cycle that regenerates SAMe depends on folate (as 5-MTHF, the active form), B12 (as methylcobalamin), B6 (as P5P), and magnesium. In women with MTHFR variants — which affect roughly 40-60% of the population to some degree — folic acid supplementation does not adequately support methylation because the conversion to active 5-MTHF is impaired. Active methylfolate is the appropriate clinical choice. This is not a minor technical distinction; it is the difference between a supplement that works and one that does not.
Gut microbiome normalisation
Reducing beta-glucuronidase activity requires restoring microbial balance. Clinically this means removing dysbiotic organisms where present (targeted antimicrobials based on stool testing results), repopulating with fibre-fermenting beneficial species (prebiotic fibre, specific probiotic strains), and improving intestinal barrier function. Calcium D-glucarate is a specific supplement that inhibits beta-glucuronidase activity directly — it is useful as an adjunct while the microbiome is being rehabilitated. Adequate dietary fibre (targeting 30+ grams daily from diverse plant sources) is non-negotiable as a baseline.
Addressing xenoestrogen burden
This is the category most practitioners underemphasise because it requires lifestyle change rather than a prescription. The evidence for cumulative xenoestrogen burden — from plastics, pesticides, conventional personal care products, and synthetic fragrances — affecting endocrine function is substantial. Australia's agricultural sector uses a significant pesticide load, including several organochlorine and organophosphate compounds with documented oestrogenic activity. The APVMA (Australian Pesticides and Veterinary Medicines Authority) regulates these, but regulatory approval does not mean zero endocrine burden — particularly with chronic, low-level cumulative exposure.
Practically: switch to glass or stainless steel food storage, filter drinking water (a basic carbon filter removes chlorine and many plasticisers), prioritise organic or low-spray produce for the foods you eat most frequently and in highest volume, and audit personal care products for parabens, phthalates, and synthetic musks. The Total Environment Centre and consumer advocacy groups in Australia have produced useful guides on lower-toxin personal care. None of these changes alone is dramatic. Cumulatively, they meaningfully reduce the total xenoestrogen load the liver has to process every day.
Dietary fibre and phytoestrogen balance
Dietary fibre binds oestrogen metabolites in the gut for elimination. Women eating higher-fibre diets consistently show lower circulating oestrogen in observational data. Flaxseed (lignans) is particularly useful — lignans are phytoestrogens with weak oestrogenic activity that compete with oestradiol for receptor binding, effectively diluting oestrogen signalling. One to two tablespoons of ground flaxseed daily is a straightforward and evidence-supported addition for women with oestrogen dominance. Fermented soy (miso, tempeh, natto) provides isoflavones with a similar receptor-competing mechanism and a better evidence profile than processed soy products.
Progesterone support where indicated
Where relative oestrogen dominance is driven by low progesterone — as is typical in perimenopause, in women with luteal phase deficiency, or in those with chronic HPA axis dysregulation — supporting progesterone is as important as clearing oestrogen. Vitex agnus-castus (chaste tree) supports progesterone production via its dopaminergic action on the pituitary. Stress management, sleep optimisation, and adrenal support are foundational — because a body in chronic cortisol overdrive will continue to sacrifice progesterone precursors regardless of what herbs are prescribed.
Ready to investigate the root cause of your hormonal symptoms?
Initial consultation is $197. No referral required. In-clinic at Kealba (Melbourne) or telehealth nationally across Australia.
Book your free discovery callFrequently asked questions
What are the most common signs of oestrogen dominance?
Heavy or painful periods, PMS (particularly mood changes and breast tenderness in the week before the period), weight gain around the hips and abdomen that resists dietary change, fluid retention in the second half of the cycle, fibrocystic breasts, low libido, and fatigue or brain fog. These symptoms can occur even when blood oestrogen levels appear within the normal reference range — because the issue is often the ratio between oestrogen and progesterone, or the way oestrogen is being metabolised, not simply the absolute level.
Can the gut cause oestrogen dominance?
Yes — and this is one of the most underappreciated mechanisms in hormonal health. Certain gut bacteria produce an enzyme called beta-glucuronidase that deconjugates oestrogen that has already been processed by the liver for elimination. Instead of leaving the body in stool, the oestrogen is reactivated and reabsorbed into circulation. A dysbiotic gut microbiome can substantially elevate circulating oestrogen independent of how well the liver is functioning. This is why gut health assessment is part of any thorough hormonal workup at this clinic.
Does DIM actually work for oestrogen dominance?
DIM (diindolylmethane) has a well-established mechanism — it shifts Phase I oestrogen metabolism toward the 2-hydroxy pathway, which produces safer, less proliferative metabolites. The clinical evidence for symptomatic improvement is reasonable but not uniform. Whether it works for a given individual depends on which part of oestrogen metabolism is impaired. If the problem is primarily beta-glucuronidase activity in the gut, or impaired methylation in Phase II, DIM alone will produce limited results. Used as part of a comprehensive protocol guided by testing, it is a useful tool. Used as a standalone supplement without understanding the pathway picture, it may underperform.
What is the best test for oestrogen dominance?
A salivary hormone panel measuring E1, E2, E3, progesterone, the E2:progesterone ratio, and cortisol gives the most useful clinical picture for most presentations. A serum oestradiol alone is insufficient because it does not capture the ratio to progesterone, the form distribution across E1, E2, and E3, or the cortisol pattern that drives progesterone depletion. Where metabolic pathway information is needed — particularly around methylation and gut dysbiosis — the Organic Acids Test and a GI Microbiome Map add significant clinical value. We use the AdrenoCortex salivary panel at this clinic.
How long does it take to clear excess oestrogen?
The honest answer is three to six months for meaningful symptomatic improvement, with the first signs of change often appearing around weeks six to eight. Oestrogen metabolism involves multiple overlapping systems — liver, gut, methylation, stress physiology — and restoring function across all of them takes time. Dietary changes tend to produce the fastest initial improvement. Gut microbiome restoration takes two to three months of consistent intervention. Methylation support and hormonal rhythm normalisation take the full three to six months. Testing at baseline and at three months allows us to track objective change and adjust the protocol as needed.
Can oestrogen dominance cause weight gain?
Yes — in two directions. Excess oestrogen promotes fat storage, particularly in the hips, thighs, and lower abdomen. And excess body fat increases oestrogen production via aromatase, creating a compounding cycle. Additionally, oestrogen dominance is frequently associated with insulin resistance and fluid retention, both of which contribute to weight that is difficult to lose with conventional dietary restriction alone. Addressing the hormonal picture — particularly the oestrogen:progesterone ratio and insulin sensitivity — is often what allows weight loss to finally occur in women who have been stuck despite consistent effort.
Do I need a referral to see a naturopath for hormonal concerns?
No referral is required. Initial consultations at Vital Health and Natural Medicine are $197 and are available in-clinic at Kealba, Melbourne, or via telehealth nationally. For patients who are unsure whether a functional hormone assessment is the right next step, a free 20-minute discovery call is the best starting point.
Related reading: Women's hormone health at Vital Health | Adrenal Cortex Female Hormone Saliva Test | Gut health and hormones | Book a discovery call
Disclaimer: This article is for educational purposes and does not constitute medical advice. If you are experiencing hormonal or gynaecological symptoms, please seek assessment from a qualified health professional. This content is prepared by Domenic Pisanelli, naturopath and functional medicine practitioner (ATMS registered), at Vital Health and Natural Medicine, 195A Sunshine Ave, Kealba VIC 3021. Phone: 03 9382 9790.
